Temps réel estimé
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
9,5 EUR | -33,00 % | -29,30 % | -56,11 % |
11:50 | RBC surperforme Evotec après les chiffres et les perspectives | DP |
11:17 | EVOTEC : Warburg Research persiste à l'achat | ZD |
Métier
Nombre d'employés: 5 086
Ventes par activité
EUR en Millions | 2021 | Poids | 2022 | Poids | Delta |
---|---|---|---|---|---|
EVT Execute
72,8
%
| 471 | 76,2 % | 547 | 72,8 % | +16,06 % |
EVT Innovate
27,2
%
| 147 | 23,8 % | 205 | 27,2 % | +39,29 % |
Ventes par région
EUR en Millions | 2021 | Poids | 2022 | Poids | Delta |
---|---|---|---|---|---|
United States
55,7
%
| 338 | 54,6 % | 418 | 55,7 % | +23,90 % |
Rest of the World
16,9
%
| 98 | 15,9 % | 127 | 16,9 % | +28,85 % |
United Kingdom
15,3
%
| 105 | 16,9 % | 115 | 15,3 % | +10,15 % |
Germany
7,8
%
| 47 | 7,6 % | 59 | 7,8 % | +25,70 % |
France
4,3
%
| 31 | 4,9 % | 32 | 4,3 % | +5,50 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 07/02/23 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 01/05/12 |
Cord Dohrmann
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/10 |
Gabriele Hansen
IRO | Public Communications Contact | - | - |
Volker Braun
IRC | Investor Relations Contact | - | - |
Matthias Evers
PRN | Corporate Officer/Principal | 51 | 01/05/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19/06/19 |
Roland Sackers
BRD | Director/Board Member | 56 | 19/06/19 |
Chairman | 63 | 17/06/14 | |
Elaine Sullivan
BRD | Director/Board Member | 63 | 09/06/15 |
Director/Board Member | 41 | 22/06/22 | |
Director/Board Member | 62 | 01/06/21 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 177 542 097 | 160 931 634 ( 90,64 %) | 249 915 ( 0,1408 %) | 90,64 % |
Participations
Nom | Actions | % | Valorisation |
---|---|---|---|
EXSCIENTIA PLC 11,86% | 14 035 200 | 11,86% | 80 281 344 $ |
Coordonnées société
Sociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Evotec International GmbH
Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Evotec International GmbH develops and provides drugs for the treatment of CNS disorders. It focuses on Alzheimer's disease and other neurological disorders. The company was founded in 1999 and is headquartered in Hamburg, Germany. |
Miscellaneous Commercial Services
|
Aptuit (Verona) Srl
Aptuit (Verona) Srl Pharmaceuticals: MajorHealth Technology Aptuit (Verona) Srl engages in the provision of integrated drug development solutions. It offers Indigo and Indigo-Select. The company was founded in 2004 and is headquartered in Verona, Italy. |
Pharmaceuticals: Major
|
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (France) SAS is a French company that engages in research and development of physical and natural sciences. The private company is based in Toulouse, France. The company was founded in 2014. Pierre Cooremans has been the CEO of the company since 2019. |
Miscellaneous Commercial Services
|
Evotec (UK) Ltd.
Evotec (UK) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Evotec SE, Evotec (UK) Ltd. provides research and development on natural sciences and engineering. The private company is based in Abingdon, UK and was founded in 1991. |
Miscellaneous Commercial Services
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-56,11 % | 2,69 Md | |
+3,13 % | 43,43 Md | |
+48,71 % | 41,69 Md | |
+8,49 % | 41,31 Md | |
-10,82 % | 27,14 Md | |
+8,26 % | 25,28 Md | |
-23,69 % | 18,47 Md | |
+1,58 % | 12,33 Md | |
+32,83 % | 12,59 Md | |
+6,63 % | 11,03 Md |
- Bourse
- Actions
- Action EVT
- Société Evotec SE